A Republican lawmaker is taking the rare and seemingly personal step of seeking to essentially eliminate top US Food and Drug Administration posts, including the Center for Drug Evaluation and Research Director, in response to agency decisions related to the abortion drug mifepristone.
Rep. Bob Good, R-VA, filed seven amendments to the House’s fiscal year 2024 Agriculture, Rural Development, FDA and Related...







